Singapore markets close in 1 hour 57 minutes

Sino Biopharmaceutical Limited (1177.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.740+0.060 (+2.24%)
As of 02:47PM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 50.36B
Enterprise value 50.38B
Trailing P/E 24.27
Forward P/E 19.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.76
Price/book (mrq)1.53
Enterprise value/revenue 1.92
Enterprise value/EBITDA 8.53

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-37.53%
S&P500 52-week change 322.64%
52-week high 34.410
52-week low 32.290
50-day moving average 32.960
200-day moving average 33.119

Share statistics

Avg vol (3-month) 352.77M
Avg vol (10-day) 378.61M
Shares outstanding 518.79B
Implied shares outstanding 619.52B
Float 89.28B
% held by insiders 148.18%
% held by institutions 115.62%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.05
Forward annual dividend yield 41.87%
Trailing annual dividend rate 30.05
Trailing annual dividend yield 31.68%
5-year average dividend yield 41.41
Payout ratio 472.63%
Dividend date 3N/A
Ex-dividend date 411 Jun 2024
Last split factor 23:2
Last split date 320 Jul 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 8.90%
Operating margin (ttm)20.76%

Management effectiveness

Return on assets (ttm)5.33%
Return on equity (ttm)12.12%

Income statement

Revenue (ttm)26.2B
Revenue per share (ttm)1.41
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 6.31B
Net income avi to common (ttm)1.85B
Diluted EPS (ttm)0.110
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.56B
Total cash per share (mrq)0.69
Total debt (mrq)12.58B
Total debt/equity (mrq)32.96%
Current ratio (mrq)1.05
Book value per share (mrq)1.66

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A